Solesence, Inc. Common Stock (NASDAQ:SLSN) — Market Cap & Net Worth
Market Cap & Net Worth: Solesence, Inc. Common Stock (SLSN)
Solesence, Inc. Common Stock (NASDAQ:SLSN) has a market capitalization of $58.62 Million ($58.62 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21235 globally and #4714 in its home market, demonstrating a -16.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Solesence, Inc. Common Stock's stock price $0.83 by its total outstanding shares 70632445 (70.63 Million). See capital reinvestment ratio of Solesence, Inc. Common Stock to understand how much of operating cash flow is reinvested back into capital assets.
Solesence, Inc. Common Stock Market Cap History: 2025 to 2026
Solesence, Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $112.66 Million to $58.62 Million (0.00% CAGR).
Solesence, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Solesence, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.82x
Solesence, Inc. Common Stock's market cap is 1.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
62.94x
Solesence, Inc. Common Stock's market cap is 62.94 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $112.66 Million | $62.06 Million | $1.79 Million | 1.82x | 62.94x |
Competitor Companies of SLSN by Market Capitalization
Companies near Solesence, Inc. Common Stock in the global market cap rankings as of August 3, 2026.
Key companies related to Solesence, Inc. Common Stock by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #46 globally with a market cap of $337.63 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #97 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #109 globally with a market cap of $188.75 Billion USD ( €161.45 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #196 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #46 | Procter & Gamble Company | NYSE:PG | $337.63 Billion | $144.49 |
| #97 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #109 | LOréal S.A. | PA:OR | $188.75 Billion | €386.95 |
| #196 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Solesence, Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Solesence, Inc. Common Stock's market cap moved from $112.66 Million to $ 58.62 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $58.62 Million | -47.96% |
| 2025 | $112.66 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Solesence, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.62 Million USD |
| MoneyControl | $58.62 Million USD |
| MarketWatch | $58.62 Million USD |
| marketcap.company | $58.62 Million USD |
| Reuters | $58.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingre… Read more